Medicine Description cardiocaps 0.25mg
Cardiocaps 0.25mg Capsule is a medication that primarily acts by increasing the force of myocardial contraction and controlling the heart rate. Digoxin, the active ingredient, inhibits the sodium-potassium ATPase enzyme, leading to an increase in intracellular sodium levels. This subsequently causes an increase in intracellular calcium concentrations, which enhances cardiac contractility. Additionally, digoxin exerts a vagomimetic effect, slowing down the conduction through the atrioventricular (AV) node, thereby reducing heart rate. This dual mechanism of action makes it particularly effective in treating certain types of heart failure and arrhythmias by improving the efficiency of the heart's pumping action and regulating rhythms.
Indications and Uses of Cardiocaps 0.25mg Capsule
- Management of heart failure, particularly in patients with reduced ejection fraction.
- Control of ventricular response rate in atrial fibrillation and atrial flutter.
- Adjunctive therapy in certain arrhythmias.
Side Effects of Cardiocaps 0.25mg Capsule
- Nausea and vomiting.
- Diarrhea.
- Fatigue and weakness.
- Visual disturbances, such as seeing halos around lights.
- Bradycardia (slow heart rate).
- Potential for digitalis toxicity, especially in cases of renal impairment.
Storage and Handling
Store Cardiocaps at room temperature, away from excess moisture and heat. Keep out of reach of children and do not use past the expiration date indicated on the packaging.
Patient Advice and Precautions
Patients should be counseled on the importance of regular monitoring of heart rate and signs of toxicity. It is critical to inform healthcare providers of any other medications being taken to avoid potential interactions. Maintain adequate hydration and report any unusual symptoms promptly.